A 57-year-old woman with A1c 9.2% and a prior MI is on metformin. eGFR 62. BP and LDL are controlled on guideline therapy. Which glucose-lowering agen...

Question

A 57-year-old woman with A1c 9.2% and a prior MI is on metformin. eGFR 62. BP and LDL are controlled on guideline therapy. Which glucose-lowering agent provides cardiovascular benefit independent of A1c reduction goals?

Accepted Answer

SGLT2 inhibitor

Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

Basal insulin

Answer

Acarbose

us-abim MCQ (SBA): Type 2 Diabetes with ASCVD

A 57-year-old woman with A1c 9.2% and a prior MI is on metformin. eGFR 62. BP and LDL are controlled on guideline therapy. Which glucose-lowering agent provides cardiovascular benefit independent of A1c reduction goals?